Xenter is a privately held TechMed company defining a new category at the intersection of medical devices, data infrastructure, and clinical AI, turning real-time high-fidelity data into a scalable intelligence layer for healthcare.
Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is building an integrated intelligence platform designed to connect medical devices, diagnostics, digital health, and AI into a seamless ecosystem that enables better clinical decision-making while continually ensuring patients control their healthcare data.
The financing attracted participation from existing shareholders, prominent family offices, and healthcare investors who share the Xenter vision of transforming the way healthcare data is captured, connected, and utilized in hospitals and physicians’ offices.
Xenter stated in its official press release that proceeds will support commercial launch, continued development of its proprietary technologies, manufacturing expansion, clinical and regulatory initiatives, and the acceleration of its integrated TechMed platform.
“The closing of Series B strongly validates Xenter’s wireless Physical Intelligence platform and enables the first commercial launch of our diagnostics business unit and the initiation of planned clinical testing of the Guru™ dual sensor physiology guidewire in Transcatheter Aortic Valve Replacement (TAVR) procedures,” said Richard J. Linder, Founder, Chairman and Chief Executive Officer of Xenter.
“This financing represents more than capital; it reflects the confidence our investors have in our long-term vision to fundamentally change how healthcare technologies communicate, generate data, and improve patient outcomes,” added Richard J. Linder.
Xenter also announced the appointment of Linda Vega to its Board of Directors. Linda brings decades of executive leadership in banking, finance, corporate governance, and strategic capital planning. A former executive with Wachovia Bank, Linda has advised organizations ranging from emerging growth companies to multinational enterprises on financial strategy, capital formation, governance, and long-term value creation.